Search Results - Mora Casterá, E

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    P1541: PRELIMINARY RESULTS OF TWO YEARS FOLLOW‐UP OF TYPE 1 GAUCHER DISEASE PATIENTS TREATED WITH ELIGLUSTAT IN TRAZELGA PROJECT

    P1541: PRELIMINARY RESULTS OF TWO YEARS FOLLOW‐UP OF TYPE 1 GAUCHER DISEASE PATIENTS TREATED WITH ELIGLUSTAT IN TRAZELGA PROJECT by Serrano‐Gonzalo, I., López de Frutos, L., Arévalo‐Vargas, I., Fernández‐Galán, M. Á., Morales‐Conejo, M., Calle‐Gordo, M. V., Vitoria‐Miñana, I., Correcher‐Medina, P., Madinaveitia‐Ochoa, A., Hernández‐Rivas, J. Á., García‐Frade, J., Ibarretxe‐Gerediaga, D., Delgado‐Mateos, F., Tormo‐Díaz, M. D. M., Ruíz‐Guinaldo, M. Á., Mora‐Casterá, E., Noya‐Pereira, M. S., Albarracín‐Arraigosa, A., López‐Dupla, M., Balanzat‐Muñoz, J., Lozano‐Almela, M. L., Labbadia, F., Andrade‐Campos, M., Giraldo, P.

    Published in HemaSphere
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    C0409: Assessment Of Different Coagulation Assays in Real Patients Under Stable Treatment with Dabigatran Etexilate and Rivaroxaban

    C0409: Assessment Of Different Coagulation Assays in Real Patients Under Stable Treatment with Dabigatran Etexilate and Rivaroxaban by Mora Casterá, E, Sánchez Sempere, M.J, Lucas, J, Jiménez, M, Giménez Richarte, Á, López, T

    Published in Thrombosis research
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion

    Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion by Castillo, Martín I., Ribate, Villamón E., Muñoz, Calabuig M., Santillana, Sanz G., Taboada, Such E., Casterá, Mora E., Abinzano, Calasanz M. J., Barranco, Irigoyen A., Nieto, Collado R., Pampliega, Vara M., Blanco, M. L., Andrés, Álvarez S., Oteyza, Pérez J., Castillo, Bernal T., Font, Granada I., Cayuela, Jerez A., Díez‐Campelo, M., Sánchez, Abellán R., Vercet, Solano C., Díaz, Tormo M.

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    PF670 MOLECULAR CLASSIFICATION OF PATIENTS WITH POLYCYTHEMIA VERA OR ESSENTIAL THROMBOCYTHEMIA WHO DEVELOP RESISTANCE OR INTOLERANCE TO HYDROXYUREA

    PF670 MOLECULAR CLASSIFICATION OF PATIENTS WITH POLYCYTHEMIA VERA OR ESSENTIAL THROMBOCYTHEMIA WHO DEVELOP RESISTANCE OR INTOLERANCE TO HYDROXYUREA by Díaz, Á., Larrán, A. Álvarez, Casterá, E. Mora, Taboada, E. Such, Figueras, A. Angona, Gómez‐Casares, M.T., Carreño‐Tarragona, G., Gutiérrez, V. García, Hernández, M.C. García, Bellosillo, B., Avetisyan, G., Cervera, J.V., Boluda, J.C. Hernández

    Published in HemaSphere
    Request full text
    Article
    Save to List
    Saved in:

Search Tools: